The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics

American Heart Journal

Volumn 157, Issue 3, 2009, Pages

  Bushnell, Cheryl ^a   Zimmer, Louise ^b   Schwamm, Lee ^c   Goldstein, Larry B ^b   Clapp Channing, Nancy ^b   Harding, Tina ^b   Drew, Laura ^b   Zhao, Xin ^b   Peterson, Eric ^b  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; FOLLOW UP; HEALTH STATUS; INFORMATION PROCESSING; INTERVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING;

EID: 60649117982     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.11.002     Document Type: Article

References (34)

1. Rosamund W., Flegal K., Furie K., et al. Heart Disease and Stroke Statistics 2008 Update: a report from the American Heart Association Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Coull A., Lovett J., and Rothwell P. Population based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organisation of services. BMJ 328 (2004) 326-328
3. Petty G., Brown R.J., and Sicks J. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 50 (1998) 208-216
4. Samsa G., Bian J., Lipscomb J., et al. Epidemiology of recurrent cerebral infarction. A Medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke 30 (1999) 338-349
5. Alberts M., and Ovbiagele B. Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol 254 (2007) 1414-1426
6. Moroney J.T., Bagiella E., Paik M.C., et al. Risk factors for early recurrence after ischemic stroke. The role of stroke syndrome and subtype. Stroke 29 (1998) 2118-2124
7. Hart R.G., Halperin J.L., Pearce L.A., et al. Lessons from the Stroke Prevention in Atrial Fibrillation Trials. Ann Intern Med 138 (2003) 831-838
8. Tran H., and Anand S.S. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 292 (2004) 1867-1874
9. Donnan G., Fisher M., Macleod M., et al. Stroke. Lancet 371 (2008) 1612-1623
10. Hankey J., and Warlow C. Treatment and secondary prevention of stroke: Evidence, costs and effects on individuals and populations. Lancet 354 (1999) 1457-1463
11. O'Rourke F., Dean N., Akhtar N., et al. Current and future concepts in stroke prevention. CMAJ 170 (2004) 1123-1133
12. Hardie K., Hankey G.J., Jamrozik K., et al. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke 35 (2004) 731-735
13. Ovbiagele B., Saver J.L., Fredieu A., et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 35 (2004) 2879-2883
14. LaBresh K., Reeves M., Frankel M., et al. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With the Guidelines" program. Arch Intern Med 168 (2008) 411-417
15. Hillen T., Dundas R., Lawrence E., et al. Antithrombotic and antihypertensive management 3 months after ischemic stroke. A prospective study in an inner city population. Stroke 31 (2000) 469-475
16. Mouradian M.S., Majumdar S.R., Senthilselvan A., et al. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack?. Stroke 33 (2002) 1656-1659
17. Rahiman A., Saver J., Porter V., et al. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis 17 (2008) 5-8
18. Morisky D., Green L., and Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986) 67-74
19. Shalansky S., Levy A., and Ignaszewski A. Self-reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications. Ann Pharmacother 38 (2004) 1363-1368
20. Safran D., Kosinski M., Tarlov A., et al. The Primary Care Assessment Survey: tests of data quality and measurement performance. Med Care 36 (1998) 728-739
21. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J 2 (1957) 200-215
22. The EuroQol Group. EuroQol*-a new facility for the measurement of health-related quality of life. Health Policy 16 (1990) 199-208
23. Spitzer R., Kroenke K., and Williams J. Patient Health Questionnaire Study Group. Validity and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA 282 (1999) 1737-1744
24. Williams L., Brizendine E., Plue L., et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 36 (2005) 635-638
25. Kroenke K., and Spitzer R. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 32 (2002) 1-7
26. World Health Organization: Adherence to long-term therapies. Evidence for action. 2003. Available at: http://www.emro.who.int/ncd/Publications/adherence_report.pdf. Last accessed July 10, 2008.
27. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am Heart J 19 (2006) 1190-1196
28. Ryan A. Medication compliance and older people: a review of the literature. Int J Nurs Stud 36 (1999) 153-161
29. Munger M., Van Tassell B., and LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. Med Gen Med 9 (2007) 58
30. Jackevicius C., Li P., and Tu J. Prevalence, predictors and outcomes of primary nonadherence after acute MI. Circulation 117 (2008) 1028-1036
31. Pit S., Byles J., and Cockburn J. Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data. Drugs Aging 25 (2008) 71-80
32. Kapral M., Laupacis A., Phillips S., et al. Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke 35 (2004) 1756-1762
33. Bhatt D., Steg P., Ohman E., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006) 180-189
34. Tu J., Willison D., Silver F., et al. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med 350 (2004) 1414-1421